» Articles » PMID: 27192564

CD28 Costimulation: From Mechanism to Therapy

Overview
Journal Immunity
Publisher Cell Press
Date 2016 May 19
PMID 27192564
Citations 414
Authors
Affiliations
Soon will be listed here.
Abstract

Ligation of the CD28 receptor on T cells provides a critical second signal alongside T cell receptor (TCR) ligation for naive T cell activation. Here, we discuss the expression, structure, and biochemistry of CD28 and its ligands. CD28 signals play a key role in many T cell processes, including cytoskeletal remodeling, production of cytokines, survival, and differentiation. CD28 ligation leads to unique epigenetic, transcriptional, and post-translational changes in T cells that cannot be recapitulated by TCR ligation alone. We discuss the function of CD28 and its ligands in both effector and regulatory T cells. CD28 is critical for regulatory T cell survival and the maintenance of immune homeostasis. We outline the roles that CD28 and its family members play in human disease and we review the clinical efficacy of drugs that block CD28 ligands. Despite the centrality of CD28 and its family members and ligands to immune function, many aspects of CD28 biology remain unclear. Translation of a basic understanding of CD28 function into immunomodulatory therapeutics has been uneven, with both successes and failures. Such real-world results might stem from multiple factors, including complex receptor-ligand interactions among CD28 family members, differences between the mouse and human CD28 families, and cell-type specific roles of CD28 family members.

Citing Articles

Multiparameter flow cytometric and transcriptional analyis of CD20 positive T-cells in bone marrow in patients of multiple myeloma and monoclonal gammopathy of undetermined significance.

Forro B, Kajtar B, Lacza A, Kereskai L, Vida L, Koszegi B Front Immunol. 2025; 16:1464940.

PMID: 40079005 PMC: 11896981. DOI: 10.3389/fimmu.2025.1464940.


Low-Dose Ionizing Radiation and Male Reproductive Immunity: Elucidating Subtle Modulations and Long-Term Health Implications.

Yin J, Ye Y, Gao Y, Xu Q, Su M, Sun S Int J Mol Sci. 2025; 26(5).

PMID: 40076897 PMC: 11900348. DOI: 10.3390/ijms26052269.


Anti-GFAP associated opsoclonus-myoclonus-ataxia syndrome in a patient with multiple autoimmune comorbidities-a case report.

Sorensen N, Nilsson A, Dos A, Stenor C J Neurol. 2025; 272(4):263.

PMID: 40072606 DOI: 10.1007/s00415-025-12999-0.


Research progress of T cells in cholangiocarcinoma.

Wang Z, Dai Y, Zhou Y, Wang Y, Chen P, Li Y Front Immunol. 2025; 16:1453344.

PMID: 40070825 PMC: 11893616. DOI: 10.3389/fimmu.2025.1453344.


Nanobody-enhanced chimeric antigen receptor T-cell therapy: overcoming barriers in solid tumors with VHH and VNAR-based constructs.

Guo S, Xi X Biomark Res. 2025; 13(1):41.

PMID: 40069884 PMC: 11899093. DOI: 10.1186/s40364-025-00755-5.


References
1.
Blanchet F, Schurter B, Acuto O . Protein arginine methylation in lymphocyte signaling. Curr Opin Immunol. 2006; 18(3):321-8. DOI: 10.1016/j.coi.2006.03.001. View

2.
Watanabe R, Harada Y, Takeda K, Takahashi J, Ohnuki K, Ogawa S . Grb2 and Gads exhibit different interactions with CD28 and play distinct roles in CD28-mediated costimulation. J Immunol. 2006; 177(2):1085-91. DOI: 10.4049/jimmunol.177.2.1085. View

3.
Long S, Cerosaletti K, Bollyky P, Tatum M, Shilling H, Zhang S . Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects. Diabetes. 2009; 59(2):407-15. PMC: 2809970. DOI: 10.2337/db09-0694. View

4.
Tan Y, Manz B, Freedman T, Zhang C, Shokat K, Weiss A . Inhibition of the kinase Csk in thymocytes reveals a requirement for actin remodeling in the initiation of full TCR signaling. Nat Immunol. 2013; 15(2):186-94. PMC: 3946925. DOI: 10.1038/ni.2772. View

5.
Borthwick N, Lowdell M, Salmon M, Akbar A . Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis. Int Immunol. 2000; 12(7):1005-13. DOI: 10.1093/intimm/12.7.1005. View